Naxitamab | m-entrepreneurship.com

Product Name :
Naxitamab

Search keywords :
3F8

drugId :
null

Target Vo:
Disialoganglioside GD2

Target Vo Short Name :
GD2

Moa_Name:
Disialoganglioside GD2 inhibitors

First Approval Country :
United States

First Approval Date Filter:
2020

Origin Company_Name :
Memorial Sloan Kettering Cancer Center

Active Company_Name :
Adium Pharma SA

Active Indication_Name:
Neuroblastoma

In Active Indication_Name:
Breast Neoplasms

Termination Status :

China Termination Status :

Highest Status:
Approved

China Highest Status:
Approved

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
N-Cadherin Antibody
Fibronectin Antibody (YA762)
SOX1 Antibody: SOX1 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 39 kDa, targeting to SOX1. It can be used for WB,ICC/IF,IHC-P assays with tag free, in the background of Human, Mouse, Rat.

Author: Betaine hydrochloride

Related Posts